Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
出版年份 2022 全文链接
标题
Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 9, Pages 4894
出版商
MDPI AG
发表日期
2022-04-29
DOI
10.3390/ijms23094894
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A meta-analysis of the association between calprotectin and the severity of COVID-19
- (2022) Qin Mao et al. JOURNAL OF INFECTION
- Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients
- (2022) Ihtzaz Ahmed Malik et al. Biology-Basel
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
- (2021) Wei Huang et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
- (2021) Ariel Munitz et al. Scientific Reports
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- IL-33 in COVID-19: friend or foe?
- (2021) Yuejin Liang et al. Cellular & Molecular Immunology
- Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
- (2021) George N. Dalekos et al. European Journal of Internal Medicine
- Circulating Calprotectin as a Biomarker of COVID-19 Severity
- (2021) Michael Mahler et al. Expert Review of Clinical Immunology
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
- (2021) Michal A. Stanczak et al. Nature Communications
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
- (2021) Konstantinos Tsiakos et al. Infectious Diseases and Therapy
- Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
- (2021) Alexander J Mentzer et al. JOURNAL OF INFECTION
- ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
- (2021) Eleni Karakike et al. Journal of Innate Immunity
- Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19
- (2021) Sarthak Sinha et al. NATURE MEDICINE
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
- (2020) Aymeric Silvin et al. CELL
- Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
- (2020) Liting Chen et al. Cellular & Molecular Immunology
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder
- (2020) Irene Tsilioni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highways to hell: mechanism based management of Cytokine Storm Syndromes
- (2020) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19
- (2020) Hui Shi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
- (2020) Qirui Guo et al. Cell Host & Microbe
- Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
- (2020) Wolfgang Bauer et al. JOURNAL OF INFECTION
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin
- (2018) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors
- (2017) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intracellular interleukin (IL)-1 family cytokine processing enzyme
- (2016) Areum Kwak et al. ARCHIVES OF PHARMACAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started